Previous 10 | Next 10 |
2024-01-29 16:31:24 ET More on Aileron Therapeutics Aileron gains after all-stock deal to acquire Lung Therapeutics Read the full article on Seeking Alpha For further details see: Aileron Therapeutics files to sell 7.06M shares for holders
2024-01-12 07:34:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Moving stocks are investments, acquisitions, new agr...
2023-12-18 08:26:30 ET Losers: Chanson International Holding ( CHSN ) -88% . Inno Holdings ( INHD ) -85% . Maison Solutions ( MSS ) -84% issues statement regarding short attack on its securities . Aadi Bioscience ( AADI ) -56% . Sing...
2023-12-15 13:25:40 ET Gainers: Getaround ( GETR ) +116% . Battalion Oil Corp ( BATL ) +82% . La Rosa Holdings Corp. ( LRHC ) +45% . Verrica Pharmaceuticals ( VRCA ) +37% . Bruush Oral Care ( BRSH ) +36% . NCS Multistage Hold...
2023-12-15 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Myomo, Aileron...
2023-12-15 08:38:22 ET Losers: Aadi Bioscience AADI -54% on study data for anti-tumor drug . Inno Holdings ( INHD ) -45% . Eos Energy Enterprises EOSE -23% announces launch of proposed $40M public offering . Chavant Capital Acquisition Corp ( CLAY...
2023-11-06 12:51:18 ET Gainers: MSP Recovery ( LIFW ) +458% . Bluegreen Vacations Holding Corporation ( BVH ) +106% . Tenon Medical ( TNON ) +72% . Cano Health ( CANO ) +43% . Cheetah Net Supply Chain Service ( CTNT ) +36% . ...
2023-11-01 14:50:52 ET More on Aileron Financial information for Aileron Therapeutics For further details see: Aileron gains after all-stock deal to acquire Lung Therapeutics
Aileron Therapeutics Announces Acquisition of Lung Therapeutics PR Newswire Acquisition includes multiple clinical stage, orphan pulmonary disease candidates, including LTI-03, a Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibros...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Aileron Therapeutics Inc. Company Name:
ALRN Stock Symbol:
NASDAQ Market:
Aileron Therapeutics Inc. Website:
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference PR Newswire AUSTIN, Texas , July 30, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first...
Aileron Therapeutics to be Included in the Russell Microcap® Index PR Newswire AUSTIN, Texas , July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of...
Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated Topline results from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) expected in ...